stoxline Quote Chart Rank Option Currency Glossary
  
Elanco Animal Health Incorporated (ELAN)
22.68  -0.77 (-3.28%)    03-12 16:00
Open: 23.11
High: 23.44
Volume: 3,190,967
  
Pre. Close: 23.45
Low: 22.515
Market Cap: 11,276(M)
Technical analysis
2026-03-12 4:44:38 PM
Short term     
Mid term     
Targets 6-month :  30.05 1-year :  32.37
Resists First :  25.73 Second :  27.71
Pivot price 24.79
Supports First :  22.52 Second :  18.73
MAs MA(5) :  23.42 MA(20) :  24.83
MA(100) :  23.24 MA(250) :  17.97
MACD MACD :  -0.4 Signal :  0
%K %D K(14,3) :  11.4 D(3) :  15.4
RSI RSI(14): 35.7
52-week High :  27.71 Low :  8.02
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ELAN ] has closed above bottom band by 8.3%. Bollinger Bands are 104.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 23.47 - 23.66 23.66 - 23.79
Low: 22.13 - 22.34 22.34 - 22.48
Close: 22.41 - 22.73 22.73 - 22.95
Company Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Headline News

Wed, 11 Mar 2026
ELAN: Raised 2026 innovation revenue targets and margin expansion driven by robust product launches - TradingView

Wed, 11 Mar 2026
UBS maintains Buy on ELAN (Elanco Animal Health Incorporated) March 2026 - Meyka

Tue, 10 Mar 2026
ELAN: Innovation and strong execution drive growth and margin expansion across all business segments - TradingView

Sat, 07 Mar 2026
Elanco Animal Health (ELAN) Price Target Increased by 14.11% to 22.35 - MSN

Tue, 03 Mar 2026
Royce & Associates LP Buys 105,632 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat

Tue, 24 Feb 2026
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 497 (M)
Shares Float 493 (M)
Held by Insiders 1.1 (%)
Held by Institutions 109.7 (%)
Shares Short 18,410 (K)
Shares Short P.Month 23,120 (K)
Stock Financials
EPS -0.47
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 13.17
Profit Margin -5 %
Operating Margin 2.2 %
Return on Assets (ttm) 1.2 %
Return on Equity (ttm) -3.7 %
Qtrly Rev. Growth 12.1 %
Gross Profit (p.s.) 5.2
Sales Per Share 9.47
EBITDA (p.s.) 1.82
Qtrly Earnings Growth 0 %
Operating Cash Flow 560 (M)
Levered Free Cash Flow 560 (M)
Stock Valuations
PE Ratio -48.26
PEG Ratio 0
Price to Book value 1.72
Price to Sales 2.39
Price to Cash Flow 20.13
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android